NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed
AstraZeneca
AIO-Studien-gGmbH
Ziekenhuis Oost-Limburg
UNICANCER
National Institutes of Health Clinical Center (CC)
Uppsala University
National Institutes of Health Clinical Center (CC)